Skip to main content
Search
section
Global
News
Careers
Language & Country Selector for Desktop
Ireland
|
en
Choose Location
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Brazil |
pt
Canada |
fr
Canada |
en
Central America |
es
Colombia |
es
Mexico |
es
United States |
en
Venezuela |
vs
Australia |
en
Bangladesh |
en
Hong Kong S.A.R. |
zh
India |
en
Indonesia |
en
Japan |
ja
Korea |
ko
Mainland China |
zh
Malaysia |
en
Pakistan |
en
Philippines |
en
Singapore |
en
Taiwan |
zh
Austria |
de
Belgium |
nl
Belgium |
fr
Bulgaria |
bg
Czech Republic |
en
Czech Republic |
cs
Denmark |
da
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Greece |
el
Hungary |
hu
Ireland |
en
Italy |
it
Latvia |
lv
Lithuania |
lt
Netherlands |
nl
Norway |
no
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Serbia |
sr
Slovakia |
sk
Spain |
es
Sweden |
sv
Switzerland |
fr
Switzerland |
de
United Kingdom |
en
Global |
en
Novartis Foundation |
en
Sandoz |
en
Egypt |
en
Israel |
he
South Africa |
en
Turkey |
tr
Language & Country Selector for Mobile
Ireland
Choose Location
europe
Americas
Asia Pacific
Europe
International
Middle East & Africa
Argentina |
es
Australia |
en
Austria |
de
Bangladesh |
en
Belgium |
nl
Belgium |
fr
Brazil |
pt
Bulgaria |
bg
Canada |
fr
Canada |
en
Central America |
es
Colombia |
es
Czech Republic |
en
Czech Republic |
cs
Denmark |
da
Egypt |
en
Estonia |
et
Finland |
fi
France |
fr
Germany |
de
Global |
en
Greece |
el
Hong Kong S.A.R. |
zh
Hungary |
hu
India |
en
Indonesia |
en
Ireland |
en
Israel |
he
Italy |
it
Japan |
ja
Korea |
ko
Latvia |
lv
Lithuania |
lt
Mainland China |
zh
Malaysia |
en
Mexico |
es
Netherlands |
nl
Norway |
no
Novartis Foundation |
en
Pakistan |
en
Philippines |
en
Poland |
pl
Portugal |
pt
Romania |
ro
Russia |
ru
Sandoz |
en
Serbia |
sr
Singapore |
en
Slovakia |
sk
South Africa |
en
Spain |
es
Sweden |
sv
Switzerland |
fr
Switzerland |
de
Taiwan |
zh
Turkey |
tr
United Kingdom |
en
United States |
en
Venezuela |
vs
Menu
About
Novartis in Ireland
Strategy
Country Leadership Team
Contact
About
Patients and Caregivers
Novartis Commitment to Patients and Caregivers
Education and Awareness
Patient Resources
Adverse Event Reporting
Novartis Societal Impact
Patients and Caregivers
Healthcare Professionals
Healthcare professional country resource
Adverse Event Reporting
Novartis Clinical Trials
Healthcare Professionals
ESG
Ethical Behavior
Code of Ethics
SpeakUp
Ethics, Risk and Compliance
Environmental Sustainability
ESG
News
News Archive
Stories
Contacts
News
Careers
Career Search
Working in Novartis Ireland
Learning and Development
Early Talent
How We Work
Well-being
Diversity & Inclusion
Awards and Recognition
Careers
Coronavirus
Coronavirus
Home
Corporate
Story Navigation
Story Navigation
All Topics
Education & Awareness
Corporate
People and Culture
icon
List View
Corporate
An Interview with our Novartis Ireland Country President
Corporate
Making Possible: Stepping toward a future with cell and gene therapy
Corporate
Novartis utilizing manufacturing capacity to help in the fight against COVID-19
Corporate
Reimagining Science in #InnovateForLife Campaign
Corporate
Novartis Announces Winners of the Innovation Prize for Assistive Tech
Corporate
Novartis Ireland is supporting #HoldFirm
Corporate
A visual tour of scientific strategies for combating coronavirus
Corporate
Novartis Ireland providing a broad range of initiatives to respond to communities impacted by COVID-19
Corporate
Novartis Partnership with Trinity Centre for People with Intellectual Disabilities
Corporate
Novartis opens facility for innovative cell and gene therapies in Switzerland
Corporate
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Corporate
Novartis Signs Collaboration Agreement to Fund Medtech Development of Low Cost Eye Monitor
